OT: Nerds chatting [Bioanalytics]

posted by nobody – 2019-03-28 11:14 (778 d 07:09 ago) – Posting: # 20101
Views: 3,971

...and even worse (re Danish footer)

The FDA ordered AbbVie to stop recruiting multiple myeloma patients for a Phase III trial of its anti-cancer drug Venclexta/Venclyxto.

Forty-one out of 194 patients taking AbbVie’s Venclexta (venetoclax) in the company’s trial have died, the FDA found, nearly twice the percent of the patients in the trial’s placebo arm.

Kindest regards, nobody

Complete thread:

 Admin contact
21,461 posts in 4,487 threads, 1,514 registered users;
online 11 (1 registered, 10 guests [including 6 identified bots]).
Forum time: Friday 19:24 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz